During the past decade, Cosmo Godino conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cosmo Godino" are "Anticoagulant-induced Bleeding" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Disease" (1 trials), "End-stage Heart Failure" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Cosmo Godino" in a lesser frequency.

Most popular intervention types in "Cosmo Godino" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antithrombotic Agent" (1 trials) and "MitraClip" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cosmo Godino" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cosmo Godino". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cosmo Godino, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cosmo Godino, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".